Botulinum toxin: clinical use
- PMID: 16870487
- DOI: 10.1016/j.parkreldis.2006.06.002
Botulinum toxin: clinical use
Abstract
Since its development for the use of blepharospasm and strabismus more than 2.5 decades ago, botulinum neurotoxin (BoNT) has become a versatile drug in various fields of medicine. It is the standard of care in different disorders such as cervical dystonia, hemifacial spasm, focal spasticity, hyperhidrosis, ophthalmological and otolaryngeal disorders. It has also found widespread use in cosmetic applications. Many other indications are currently under investigation, including gastroenterologic and urologic indications, analgesic management and migraine. This paper is an extensive review of the spectrum of BoNT clinical applications.
Similar articles
-
Botulinum toxin in movement disorders.Semin Neurol. 2007 Apr;27(2):183-94. doi: 10.1055/s-2007-971171. Semin Neurol. 2007. PMID: 17390263 Review.
-
Pharmacotherapy with botulinum toxin: harnessing nature's most potent neurotoxin.Pharmacotherapy. 2000 Sep;20(9):1079-91. doi: 10.1592/phco.20.13.1079.35040. Pharmacotherapy. 2000. PMID: 10999501 Review.
-
The current use of botulinum toxin.J Clin Neurosci. 2000 Sep;7(5):389-94. doi: 10.1054/jocn.2000.0684. J Clin Neurosci. 2000. PMID: 10942658 Review.
-
Botulinum toxin: State of the art.Mov Disord. 2017 Aug;32(8):1131-1138. doi: 10.1002/mds.27072. Epub 2017 Jun 22. Mov Disord. 2017. PMID: 28639368 Review.
-
Therapeutic uses of botulinum toxin.Am Fam Physician. 1997 Feb 1;55(2):541-5, 548. Am Fam Physician. 1997. PMID: 9054223 Review.
Cited by
-
Efficacy and Safety of Long-Term Therapy with Type A Botulinum Toxin in Patients with Blepharospasm.Neuroophthalmology. 2018 Nov 26;43(5):277-283. doi: 10.1080/01658107.2018.1542009. eCollection 2019 Nov. Neuroophthalmology. 2018. PMID: 31741669 Free PMC article.
-
Patient Perspectives on the Therapeutic Profile of Botulinum Neurotoxin Type A in Spasticity.Front Neurol. 2020 May 7;11:388. doi: 10.3389/fneur.2020.00388. eCollection 2020. Front Neurol. 2020. PMID: 32477251 Free PMC article.
-
An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists.Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2602-7. doi: 10.1073/pnas.0611213104. Epub 2007 Feb 9. Proc Natl Acad Sci U S A. 2007. PMID: 17293454 Free PMC article.
-
'Similar to' is not 'identical with', and 'identical with' is not 'the same as'.Drugs R D. 2015 Mar;15(1):11-2. doi: 10.1007/s40268-015-0086-8. Drugs R D. 2015. PMID: 25735937 Free PMC article. No abstract available.
-
Patient perspectives on the therapeutic profile of botulinum neurotoxin type A in cervical dystonia.J Neurol. 2021 Mar;268(3):903-912. doi: 10.1007/s00415-020-10217-7. Epub 2020 Sep 16. J Neurol. 2021. PMID: 32939574 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical